Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Hepion Pharmaceuticals Inc
HEPACurrent price
0.64 USD
+0.02 USD (+3.24%)
Last closed
0.64 USD
Company
www.hepionpharma.com
ISIN
US4268971045
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 769 434 USD
Yield for 12 month
-79.35 %
1Y
3Y
5Y
10Y
15Y
HEPA
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+109 730 USD
Current Year
-67 131 USD
Last Year
-77 461 USD
Current Quarter
–
Last Quarter
-30 758 USD
Key Figures HEPA
1 year
3 years
5 years
10 years
EBITDA
-31 507 800 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-92.82 %
PEG Ratio
–
Return On Equity TTM
-189.52 %
Wall Street Target Price
30 USD
Revenue TTM
–
Book Value
0.32 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-6.41 USD
Diluted Eps TTM
-6.41 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics HEPA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HEPA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
11.05.2023
Dividend Date
03.06.2019
Stock Valuation HEPA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.0958
Price Book MRQ
2.0193
Financials HEPA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HEPA
For 52 weeks
0.55 USD
4.47 USD
50 Day MA
0.7 USD
Shares Short Prior Month
25 113
200 Day MA
1.33 USD
Short Ratio
0.85
Shares Short
18 894
Short Percent
0.33 %
BeatStart